Bard C R Inc (BCR) Return on Equity ROE from the third quarter 2017 to third quarter 2016 and annually, average high and low, overall ranking from Sep 30 2017 to Sep 30 2016 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bard C R Inc  (BCR)

Bard C R Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bard C R Inc in the third quarter 2017?
Bard C R Inc achieved a return on average equity (ROE) of 31.67 % in its third quarter 2017, this is above BCR's average return on equity of 22.85%.
Bard C R Inc shareholder's equity over the 12 months ending in its third quarter 2017 are valued at $1,805 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 5 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2017 from 171 to 192.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2017)
III. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter
Y / Y Equity Change 17.18 % 13.93 % 14.51 % 15.1 % -
Y / Y Net Income Change -2.39 % -11.81 % 53.27 % 17.09 % -
Net Income (TTM) in Millions 572 574 592 531 507
Return On Equity (TTM) 31.67 % 33.15 % 35.39 % 32.73 % 32.39 %
BCR's Total Ranking # 192 # 171 # 172 # 0 # 0
Equity (TTM) in Millions 2,018 1,855 1,672 1,675 1,722
Seq. Equity Change 8.81 % 10.93 % -0.2 % -2.73 % 5.79 %
Seq. Net Income Change -32.64 % -21.56 % 11.59 % 65.56 % -39.14 %

Back to BCR Management Effectiveness >> BCR's 5 Years Annual ROE >> Compare BCR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 32
Overall # 192

Return On Equity Statistics
High Average Low
43.26 %
22.85 %
7.39 %
(Sep. 28, 2014)   (Mar 31 2016)





BCR Annual Return On Equity (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (FY 2014)
(Dec. 31. 2014)		 (Dec 31 2013)
2013		 (FY 2012)
(Dec. 31. 2012)
Total Equity in Millions 1,675 1,455 1,805 2,088 1,926
Y / Y Equity Change 15.1 % -19.37 % -13.57 % 8.44 % 8.05 %
Net Income in Millions 531 135 295 690 530
Y / Y Net Income Change 292.47 % -54.02 % -57.31 % 30.13 % 61.62 %
Return On Equity 31.72 % 9.3 % 16.32 % 33.03 % 27.53 %

Back to BCR Management Effectiveness >> BCR's 5 Years Annual ROE >> Compare BCR ROE to its Competitors




Annual Roe Comment
In 2016 ROE improved to 31.72 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BCR's' Return on Equity at Yahoo Finance
BCR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BCR's Competitors
Subscribers only: Roe for Bard C R Inc's Suppliers
Subscribers only: Return On Equity for BCR's Customers




Companies with similar Return On Equity at Sep 30 2017, within Healthcare Sector ROE
Optec International, Inc.  78.00 %
Lisata Therapeutics Inc   69.78 %
Eagle Pharmaceuticals inc   59.03 %
Corcept Therapeutics Inc  58.16 %
Cba Florida Inc   57.30 %
Mimedx Group Inc   56.49 %
Zoetis Inc   54.27 %
Masimo Corp  52.60 %
Gilead Sciences Inc   52.26 %
Phibro Animal Health Corporation  49.65 %
Ligand Pharmaceuticals Incorporated  48.67 %
3m Company  48.64 %
Sonoma Pharmaceuticals Inc   44.70 %
Opiant Pharmaceuticals Inc   42.36 %
Pro dex Inc   41.88 %
Jrsis Health Care Corp  40.60 %
Luna Innovations Inc  38.02 %
Psychemedics Corporation  37.32 %
Biodelivery Sciences International Inc   33.82 %
Bausch Health Companies Inc   33.64 %
Bard C R Inc  31.67 %
Oramed Pharmaceuticals Inc  30.27 %
Biogen Inc   29.02 %
Encompass Health Corporation  28.87 %
Illumina Inc   28.01 %
Bristol myers Squibb Company  27.73 %
Tivity Health Inc   27.62 %
Ethema Health Corporation   27.55 %
Remedent Inc   27.21 %
Supernus Pharmaceuticals inc   26.37 %

Date modified: 2026-09-08T15:08:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.